NCT01373476 Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy Status COMPLETED Phase PHASE2
NCT01364129 The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy Status COMPLETED Phase NA
NCT01323348 Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Status COMPLETED Phase PHASE3
NCT01320345 The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01306981 Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study Status COMPLETED Phase PHASE4
NCT01304225 Panretinal Photocoagulation for Diabetic Retinopathy With PASCAL Laser Status UNKNOWN Phase PHASE3
NCT01298076 Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema Status COMPLETED Phase PHASE2
NCT01257815 Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment Status COMPLETED Phase PHASE4
NCT01255293 Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments Status COMPLETED Phase NA
NCT01223612 Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation Status COMPLETED Phase PHASE4
NCT01220804 Evaluation of Blood-retinal Barrier Functional Alterations by Optical Coherence Tomography Status COMPLETED Phase N/A
NCT01213888 Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy Status TERMINATED Phase NA
NCT01202461 Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME) Status COMPLETED Phase PHASE1
NCT01189461 Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema Status COMPLETED Phase PHASE3